SCHEMBL4166897

SCHEMBL4166897

NC(=O)[C@H](CCCSCC(=O)C(F)(F)F)NC(=O)c1cn[nH]c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 7/20 0.41
PADI1 Q9ULC6 6/20 0.39
PADI2 Q9Y2J8 4/20 0.39
PADI3 Q9ULW8 4/20 0.39
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
CES1 P23141 6/20 0.36
PDE4A P27815 3/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
FAAH O00519 4/20 0.35
CES2 O00748 2/20 0.35
PLA2G6 O60733 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA9 Q16790 2/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
PTPN1 P18031 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4156142 0.83 ROCK2 (0.38) HDAC1HDAC2ROCK2
SCHEMBL4156708 0.82 CCKBR (0.34) HDAC1HDAC2CES1
SCHEMBL4168844 0.81 PLOD2 (0.46) PADI4PADI1PADI2PADI3HDAC1
SCHEMBL4166903 0.81 CES1 (0.36) HDAC1HDAC2CES1FAAHCES2
Trifluoroacetic Acid SCHEMBL4157968 0.79 PADI4 (0.49) PADI4PADI1PADI2PADI3HDAC1
SCHEMBL4159878 0.76 ROCK2 (0.45) HDAC1HDAC2ROCK2ROCK1
SCHEMBL4156148 0.74 CES1 (0.31) HDAC1HDAC2CES1FAAHCES2
SCHEMBL4156709 0.73 CES1 (0.31) HDAC1HDAC2CES1
SCHEMBL4166891 0.72 CES1 (0.52) PADI4PADI1PADI2PADI3HDAC1
Trifluoroacetic Acid SCHEMBL4304780 0.70 CES1 (0.50) PADI4PADI1PADI2PADI3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 PADI4 374/4885PADI1 314/4885PADI2 495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.